Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01542372 · ClinicalTrials.gov registry record · Phase 4
Two Stepped Care Models for Posttraumatic Stress Disorder (PTSD) Among Cambodian Refugees With PTSD
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 114
- Enrollment target
NCT01542372: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01542372 is a Phase 4 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01542372, a Phase 4 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 114 participants
- Enrollment target
Study Summary
This project aims to investigate the efficacy of two models to treat Posttraumatic Stress Disorder (PTSD) for Cambodian refugees in primary care. The first step in both models is giving a medication, which is a serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor (SSRI/SSRN), with paroxetine being the first-line agent. For those patients who still have PTSD, the second step is either another medication or a culturally sensitive cognitive behavioral therapy (CBT). The investigators hypothesize that patients will improve in both models, but more so in the the CBT model.
Interventions
- BEHAVIORAL CBT
- DRUG Medication augmentation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01542372
The ClinicalTrials.gov registry entry for NCT01542372 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CBT is the first listed.
NCT01542372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01542372 about?
NCT01542372 is a clinical study titled "Two Stepped Care Models for Posttraumatic Stress Disorder (PTSD) Among Cambodian Refugees With PTSD". This project aims to investigate the efficacy of two models to treat Posttraumatic Stress Disorder (PTSD) for Cambodian refugees in primary care. The first step in both models is giving a medication, which is a serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor (SSRI/SSRN), wit...
What is the current status of trial NCT01542372?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 114 participants. The study started on 2012-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01542372?
The interventions under investigation include: CBT (BEHAVIORAL), Medication augmentation (DRUG).
Who is sponsoring clinical trial NCT01542372?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.